A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease

LECIG infusion is a viable treatment option for PD patients with motor fluctuations, for up to 4 years in our cohort.

Authors

Institutions

Publication Details

Journal
Movement Disorders Clinical Practice
Published
2024-10-24
DOI
https://doi.org/10.1002/mdc3.14240
Citations
7
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
2.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease

Dag Nyholm, Mezin Öthman
7 citations
Movement Disorders Clinical Practice
Parkinson's Disease Mechanisms and Treatments
2.58
article

A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease

Dag Nyholm, Mezin Öthman
article en
7 citations

Abstract

LECIG infusion is a viable treatment option for PD patients with motor fluctuations, for up to 4 years in our cohort.

Movement Disorders Clinical PracticeVol. 11(12)
Uppsala University (SE)
Britannia Pharmaceuticals
Openalex Percentile: Top 9%
Parkinson's Disease Mechanisms and Treatments
2.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A 4‐Year Follow‐Up of Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Parkinson's Disease — Dag Nyholm, Mezin Öthman · Movement Disorders Clinical Practice (2024) | TGRS Research Map | TGRS